MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding publication of Un-Audited Financial Results for the period ended December 31, 202214-02-2023
14-02-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Financial Results- For The Period Ended DECEMBER 31, 2022
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., February 13, 2023 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the period ended December 31st, 2022 along with the Limited Review Report on the un-audited results pursuant to Regulation 33 of the Listing Regulations;13-02-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Monday, February 13, 2023
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., February 13, 2023 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the period ended December 31st, 2022 along with the Limited Review Report on the un-audited results pursuant to Regulation 33 of the Listing Regulations;13-02-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended December 31, 2022(Q3).
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform your good office that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 13, 2023 at 04:00 p.m. at the registered office of the Company at Mumbai, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31, 2022(Q3).06-02-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 03, 2023 for Shree Kishoriju Trading and Investments Pvt Ltd03-02-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 31, 2023 for Shree Kishoriju Trading and Investments Pvt Ltd31-01-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 19, 2023 for Shree Kishoriju Trading & Investments Pvt Ltd19-01-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 13, 2023 for Shree Kishoriju Trading and Investments Pvt Ltd13-01-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate for the quarter ended 31st December 202209-01-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shweta Dhoot & Others30-12-2022